Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Crespo

Showing results (341-350 of 366) with videos related to

Pageof 37
Sort By:
Nature Communications|November 26, 2022
Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damageIrene González-Recio, Jorge Simón, Naroa Goikoetxea-Usandizaga, et al.
JHEP Reports : Innovation in Hepatology|September 22, 2025
Autoantibodies are associated with worse outcomes in MASLDAnna Soria, Alba Díaz, Paula Iruzubieta, et al.
Journal of Hepatology|February 11, 2021
Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASHJorge Simón, Naroa Goikoetxea-Usandizaga, Marina Serrano-Maciá, et al.
Hepatology (Baltimore, Md.)|March 30, 2023
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation studyJenny Lee, Max Westphal, Yasaman Vali, et al.
Cell Reports. Medicine|July 17, 2024
Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathwayClàudia Gil-Pitarch, Marina Serrano-Maciá, Jorge Simon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2017
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4Zoe Mariño, Juan M Pascasio-Acevedo, Adolfo Gallego, et al.
Annals of Hepatology|January 20, 2026
Overcoming barriers to HCV screening in Latin America: from evidence to actionJavier Crespo, Jose Luis Calleja, Ezequiel Ridruejo, et al.
Journal of Hepatology|September 23, 2021
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial functionNatália da Silva Lima, Marcos F Fondevila, Eva Nóvoa, et al.
Cancer Research|March 27, 2021
E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting EnvironmentFrancisco González-Romero, Daniela Mestre, Igor Aurrekoetxea, et al.
Hepatology (Baltimore, Md.)|February 27, 2022
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profilesIbon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, et al.
Pageof 37

Showing results (341-350 of 366) with videos related to

Sort By:
Pageof 37
Nature Communications|November 26, 2022
Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damageIrene González-Recio, Jorge Simón, Naroa Goikoetxea-Usandizaga, et al.
JHEP Reports : Innovation in Hepatology|September 22, 2025
Autoantibodies are associated with worse outcomes in MASLDAnna Soria, Alba Díaz, Paula Iruzubieta, et al.
Journal of Hepatology|February 11, 2021
Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASHJorge Simón, Naroa Goikoetxea-Usandizaga, Marina Serrano-Maciá, et al.
Hepatology (Baltimore, Md.)|March 30, 2023
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation studyJenny Lee, Max Westphal, Yasaman Vali, et al.
Cell Reports. Medicine|July 17, 2024
Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathwayClàudia Gil-Pitarch, Marina Serrano-Maciá, Jorge Simon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2017
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4Zoe Mariño, Juan M Pascasio-Acevedo, Adolfo Gallego, et al.
Annals of Hepatology|January 20, 2026
Overcoming barriers to HCV screening in Latin America: from evidence to actionJavier Crespo, Jose Luis Calleja, Ezequiel Ridruejo, et al.
Journal of Hepatology|September 23, 2021
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial functionNatália da Silva Lima, Marcos F Fondevila, Eva Nóvoa, et al.
Cancer Research|March 27, 2021
E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting EnvironmentFrancisco González-Romero, Daniela Mestre, Igor Aurrekoetxea, et al.
Hepatology (Baltimore, Md.)|February 27, 2022
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profilesIbon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, et al.
Pageof 37